Tracked deals
206
206 tracked deals across 2015-2026.
Tracked deals
206
206 tracked deals across 2015-2026.
Buyer mix
Strategic-led
185 strategic · 62 pe
Top trend
Volume peaked in 2026
54 tracked deals announced in 2026.
Primary Insight
| Province/Region | Examples of deal activity | Common theme |
|---|---|---|
| Alberta | Canada Diagnostic Centres (Shift Imaging, Grande Prairie); other transactions with Alberta locations | Regional expansion of services |
| Ontario | SteriMax (Andone Pharmaceuticals); PharmaCorp RX (PharmaChoice banner pharmacy) | Expanding healthcare platforms via acquisitions |
| Quebec | Polar Valley Investments purchase from Québec restructuring | Acquisitions following creditor-protection outcomes |
| British Columbia | GuideAI Health business combination closing | Platform build-outs via corporate arrangements |
Build a buyer list for your Healthcare Services deal
Find buyers actively acquiring healthcare services companies.
Find buyers like these for your dealBuyer Snapshot
Illustrative buyers pulled from tracked transactions on this page. This table is capped and intentionally non-exhaustive.
| Buyer | # Deals | Focus | Type |
|---|---|---|---|
| WELL Health Technologies Corp. | 10 | Publicly traded Canadian healthcare technology company th... | Strategic |
| Mednow Inc. | 6 | Canada-based virtual pharmacy and healthcare technology c... | Strategic |
| Peloton Capital Management | 6 | Toronto-based private equity firm focused on North Americ... | PE |
| Persistence Capital Partners | 5 | Healthcare-focused private equity firm and largest shareh... | PE |
| PharmaCorp Rx Inc. | 5 | Canadian pharmacy acquisition and ownership platform that... | Strategic |
| INTEGRAcare Inc. | 4 | Toronto-based private nursing and home healthcare provide... | Strategic |
| Canada Diagnostic Centres | 3 | Multi-modality diagnostic imaging provider operating clin... | Strategic (PE-backed) |
| L Catterton | 3 | Consumer-focused private equity firm managing global priv... | PE |
| Mable Health Inc. | 3 | Canadian healthcare platform that acquires and operates o... | Strategic (PE-backed) |
| SeaFort Capital | 3 | Halifax-based private equity firm investing in lower-mid-... | PE |
Last 9 years
Supporting Data
Everest Clinical Research (“Everest”) announced the acquisition of the Biometrics and Data Services business unit of Firma Clinical Research (“Firma DS”). The deal expands Everest’s global biometrics expertise and clinical data science capabilities, adding an experienced biometrics team and supporting clients across the clinical development lifecycle.
L Catterton and Altas Partners agreed to acquire a majority stake in Fullscript from HGGC and Snapdragon Capital Partners. The investment is intended to support Fullscript’s next phase of expansion, including growth of its platform and clinical support capabilities, ahead of a planned close in Q4 2026 subject to regulatory approvals and customary conditions.
Empire Company Limited, through its wholly owned subsidiary Sobeys Inc., has entered into an agreement to acquire nine Morelli's pharmacies co-located in Longo's grocery stores in Ontario. Each pharmacy will be integrated into Sobeys National Pharmacy operations and rebranded as a Longo's Pharmacy, subject to regulatory approvals, with an expected close in Q2 fiscal 2027.
Kirin Holdings Company, Limited has entered into a definitive arrangement agreement to acquire all issued and outstanding shares of Jamieson Wellness for C$45.75 per share in cash. The C$2.5 billion enterprise value transaction is expected to close in the fourth quarter of 2026, subject to shareholder, court, and regulatory approvals.
BWX Technologies, Inc. (BWXT) has entered into a definitive agreement to sell its medical business to Nordic Capital for up to $800 million. The transaction includes BWXT Medical and Kinectrics’ stable medical isotopes business, and BWXT expects the deal to close by the end of 2026 subject to regulatory approvals.
KGK Science Inc. received a growth investment led by Maxim Partners to expand its clinical research and regulatory services. The transaction closed on June 30, 2026; financial terms were not disclosed.
Prima Living, a division of Primacorp Ventures Inc., completed its nearly $117.9 million acquisition of nine senior living communities in Ontario from Chartwell Retirement Residences, adding 689 units. The deal expands Prima Living’s Ontario footprint and brings its total portfolio to 1,187 suites across Canada.
The Hatheway Group of Companies acquired five orthodontic practices in Fredericton, Bedford, Halifax, Sydney, and Truro from Canadian Orthodontic Partners. The deal expands Hatheway’s Maritime orthodontic clinic portfolio to seven locations across New Brunswick and Nova Scotia, with clinics continuing to serve their existing patient bases.
Replenish Nutrients Holding Corp. entered into a $15 million strategic investment with SRC Agrominerals, consisting of a $7.5 million equity investment and a $7.5 million senior secured convertible debenture. SRC is taking an initial 19.9% (non-diluted) stake and adding board representation as Replenish funds its Beiseker, Alberta pelletization expansion and related working-capital needs. The parties also signed a 10-year carbonatite supply agreement to secure a key input for Replenish’s regenerative fertilizer products.
Malar Group, a Canadian investment firm led by CEO Sayan Navaratnam, announced the acquisition of and strategic growth investment in Ecoideas Innovations Inc., the Canadian parent company behind the Ecoideas natural health brand. The company will be renamed Velora Inc., with CEO Rafic Sidani and the existing leadership team continuing to run the business. Financial terms were not disclosed.
Premier Health of America’s Québec CCAA restructuring culminated in a court-approved reverse-vesting transaction, under which Polar Valley Investments acquired the equity interests in three operating affiliates—Solutions Staffing Inc., Canadian Health Care Agency Ltd., and Premier Soin Nordik / Premier Health Nordik. The acquired units exited creditor protection as going concerns, retained necessary assets and liabilities, and are expected to experience no changes to day-to-day operations for clients.
Canada Diagnostic Centres (CDC), a Novacap portfolio company, announced the acquisition of Shift Imaging, a diagnostic imaging clinic based in Grande Prairie, Alberta. The deal expands CDC’s geographic presence in Northern Alberta (Peace Region) and improves access to community-based diagnostic imaging services for patients and referring healthcare professionals.
SteriMax Inc. acquired Andone Pharmaceuticals Inc., a Canadian pharmaceutical and medical device company based in Oakville, Ontario. The acquisition strengthens SteriMax’s position as one of Canada’s largest privately owned pharmaceutical companies and expands its platform into medical device and veterinary markets. Financial terms were not disclosed, and Andone founder Jay Barat will join SteriMax to lead its veterinary and medical device businesses.
PharmaCorp RX Inc. completed its previously announced acquisition of a 100% interest in a PharmaChoice Canada-bannered pharmacy in Ontario for approximately $8.1 million, funded with existing cash resources. The acquisition increases PharmaCorp’s operating network to 15 pharmacies, and PharmaCorp also disclosed a separate Western Canada acquisition under a definitive agreement expected to close on or about August 17, 2026 (subject to customary conditions).
Altea Active Club Inc. announced it received a significant minority investment from Walter Capital Partners Inc. The funding is intended to accelerate Altea’s national rollout of premium, community-oriented fitness and wellness clubs across Canada, including new club development in high-growth urban markets.
GuideAI Health Corp. (formerly 1532139 B.C. Ltd) completed a business combination with GuideAI Health, Inc. via a plan of arrangement under the British Columbia Business Corporations Act, where a wholly owned subsidiary acquired all outstanding shares of Guide Health. In connection with the closing, the company also completed a brokered private placement of 5,150,000 subscription receipts, with proceeds subject to escrow release conditions.
KKR will make a strategic investment in FYihealth group (the parent of FYidoctors, Visique, BonLook, and solis optics) through its Ascendant Fund. The investment is intended to accelerate the doctor-led clinical model, expand access to eye care in underserved communities, and grow US operations alongside continued A.I. and digital infrastructure development.
Vireo Growth Inc. has entered into a definitive arrangement agreement to acquire all issued and outstanding shares of C21 Investments Inc. in exchange for Vireo shares. The deal is expected to expand Vireo’s footprint in Nevada with approximately 15 dispensaries and 158,000 square feet of cultivation and manufacturing capacity.
Merrithew International Inc. announced the acquisition of the GYROTONIC organization, creator of the GYROTONIC and GYROKINESIS movement methods. The deal is intended to strengthen Merrithew’s global leadership in mindful movement education, training, and equipment by expanding its education and programming portfolio.
PharmaEssentia Corporation announced it will acquire 100% of Canadian specialty pharmaceutical company FORUS Therapeutics Inc. in a transaction valued at US$36.5 million. The deal is intended to deepen PharmaEssentia’s presence in Canada’s hematology-oncology myeloproliferative neoplasm (MPN) market and accelerate commercialization of BESREMi (ropeginterferon alfa-2b) by integrating FORUS’s regulatory, medical, and commercial capabilities.
Red White & Bloom Brands, through its wholly owned subsidiary Emblem Cannabis Corporation, has completed the acquisition of Ayurcann in a court-supervised CCAA sale process. The deal adds the Fuego, Xplor and Happy & Stoned vape and pre-roll brands, a Health Canada-licensed formulation/manufacturing and packaging facility in Pickering, Ontario, and national distribution across eight provinces and territories.
PharmaCorp RX Inc. has entered into a definitive share purchase agreement to acquire a 100% interest in a PharmaChoice Canada bannered pharmacy located in Morrisburg, Ontario, from an arm's-length vendor group. The deal has an aggregate purchase price of approximately $8.2 million and is expected to close within about 60 days, subject to customary conditions including Ontario College of Pharmacists approval.
Canada Life has acquired Santé Circle Health, a provider of disability management and occupational health services. The acquisition is intended to strengthen and modernize Canada Life’s disability offering, including capabilities such as early intervention, provider management and digital intake.
Cannara Biotech Inc. has completed its acquisition of all shares of Medican Organic Inc. for an aggregate purchase price of CAD $2.8 million. The deal adds Medican’s cultivation, post-harvest, and extract manufacturing know-how, following Cannara’s earlier purchase of Medican’s Valleyfield cultivation and manufacturing facility in 2021.
Nova Leap Health Corp.’s Canadian subsidiary, Earth Angels Home Care, completed the acquisition of Parkwood Home Care Limited’s shares. The deal closed on May 1, 2026 for total consideration of CAD 3.5 million, with CAD 3.2 million paid in cash and CAD 0.3 million paid via a three-year promissory note.
PharmaCorp Rx Inc. entered into definitive share purchase agreements to acquire an aggregate 100% interest in eight PharmaChoice Canada-bannered pharmacies in Eastern Canada for approximately $24.2 million. The acquisitions were expected to close within 60 days subject to customary conditions, and PharmaCorp later announced completion of the acquisition, increasing its store count from six to fourteen locations.
Red Light Holland Corp. acquired Filament Health Corp. through a statutory plan of arrangement effective April 29, 2026. The deal creates a vertically integrated psychedelic platform spanning IND-enabled development, controlled-substance licensing/compliance, and global commercialization and distribution.
Vigilance Santé, a Canadian provider of clinical decision support software and medication databases, has acquired MedSafer, a Quebec-based company that developed and validated deprescribing decision-support tools. The acquisition is intended to strengthen Vigilance Santé’s ability to help clinicians optimize medication use for older adults and expand its capacity in Canada.
Purkinje announced its acquisition of LeoMed Technologies, a virtual care platform focused on hospital-at-home services and other patient-at-home offerings. Purkinje said the deal will integrate LeoMed to accelerate deployment of digital solutions, streamline clinical workflows, and strengthen coordination and monitoring from hospital to home.
Westland Benefits, the employee benefits division of Westland Insurance Group, acquired Chilliwack, British Columbia–based Synchronized Employee Benefits Corporation effective April 16, 2026. The deal expands Westland Benefits’ national advisory capabilities and grows its footprint in the Fraser Valley while maintaining a client-centric, local-service approach.
Kindred Home Care Inc. acquired TLC Nursing Home Care Services Limited to expand its home care footprint into Newfoundland and Labrador. The transaction closed on April 1, 2026, and financial terms were not disclosed.
Emcure Pharmaceuticals’ step-down subsidiary, Mantra Pharma Inc. (Canada), acquired 100% of Cutimed Inc. for up to CAD 5.05 million. Immediately after the acquisition, Cutimed was amalgamated with Mantra effective April 1, 2026 to streamline operations and improve administrative efficiencies, strengthening Emcure’s Canadian cosmetic and dermatological product presence.
Extendicare completed the acquisition of CBI Home Health LP and CBI (GP) 3 Inc. and their subsidiaries for a cash purchase price of $570.0 million, plus approximately $13.6 million in estimated lease liabilities (IFRS 16). The deal was completed on April 1, 2026 through Extendicare’s wholly-owned subsidiary, ParaMed Inc., with funding from a private placement, draws under Extendicare’s credit facility, and cash on hand.
Blue Cross Life Insurance Company of Canada agreed to acquire StanCorp Financial Group’s Canadian voluntary benefits business, which offers critical illness and accident insurance. The acquisition (covering about 170,000 employees and their families) was expected to close in late 2026 pending regulatory approvals, and is later reported as closed on July 3, 2026.
Idealist Capital led a C$50 million growth equity investment in sustainable agriculture company Solugen Global. The Canada Growth Fund also participated in the equity commitment as Solugen plans to scale production of its low-carbon, fast-release fertilizer Azogen.
WELL Health Technologies’ majority-owned subsidiary WELLSTAR completed the acquisition of two medical billing assets: PatientSERV in Ontario and Lambert Médico Factures in Québec. The deals expand WELLSTAR’s national medical billing platform, extending coverage to six Canadian provinces and strengthening its clinical operations offering for physicians.
Canopy Growth Corporation completed its previously announced arrangement to acquire all issued and outstanding common shares of MTL Cannabis Corp., making MTL a wholly owned subsidiary. The deal strengthens Canopy Growth’s Canadian medical cannabis platform and expands premium flower supply and operations to better serve regulated international medical markets, including Europe.
Crescita Therapeutics Inc. has entered into a definitive arrangement agreement to be acquired by ClinActiv Holdings Inc. in an all-cash transaction valued at $0.80 per share (minimum $0.75 per share), subject to working-capital adjustments. The transaction is expected to close in the second quarter of 2026 and will result in Crescita shares being delisted from the Toronto Stock Exchange, with a post-closing reorganization in which ClinActiv retains the commercial skincare and contract manufacturing business.
Hydreight Technologies Inc. closed a $300,000 strategic investment in Insu Therapeutics Inc. through the acquisition of 800,000 units at $0.375 per unit under a subscription agreement dated March 4, 2026. Each unit consists of one Insu common share and one warrant to purchase one Hydreight common share, with Hydreight also receiving exclusive U.S. distribution rights for peptide therapeutics using Insu’s buccal delivery technology, subject to regulatory approvals.
Equinoxe LifeCare, a Quebec-based private homecare provider, has acquired a majority stake in Ottawa-based Choice Homecare through a strategic alliance. The deal is intended to strengthen Equinoxe’s national footprint in Canada and expand homecare services in Ontario.
Spring Living Retirement Communities has acquired six retirement residences in Eastern Ontario, totaling 766 suites. The properties include Westwood Retirement Community in Ottawa plus five Ontario communities, expanding Spring Living’s senior living footprint to 29 properties and 3,500 suites across Ontario and Québec.
Octane Medical Group entered into a definitive agreement to acquire Lonza’s Personalized Medicine business, including Lonza’s controlling stake in the Cocoon cell-therapy platform plus related intellectual property, workforce, and existing customer contracts. The transaction is expected to close by the end of Q1 2026, subject to customary closing conditions.
BioSyent Inc. has successfully closed its previously announced acquisition of Oral Science Inc. for a total purchase price of $25.5 million. The deal was completed via a share purchase agreement dated February 8, 2026, with consideration paid through a mix of cash and BioSyent shares, and includes contingent earn-out and royalty payments.
fdp Private Wealth Management announced the immediate acquisition of a majority interest in MultiD, a Quebec-based medical billing and administrative solutions firm. The deal is intended to create a fully integrated medical-finance offering for physicians across Quebec while maintaining MultiD’s brand and service continuity.
Exact Imaging, a developer of high-resolution micro-ultrasound for urologic imaging, announced the closing of a $10 million financing round led by iGan Partners. The proceeds will be used to accelerate global sales and adoption of its ExactVu prostate biopsy system.
Apollo Global Management will acquire a minority stake in The GoodLife Group, Canada’s largest gym operator, with terms not disclosed. The investment is intended to provide capital to advance GoodLife’s long-term growth strategy while keeping founder David “Patch” Patchell-Evans and CEO Jeff van Haeren in place.
GreenShield has acquired Kii Health’s Canadian mental health services segment, including EFAP, Student Assistance Program (SAP), CBT Associates, and TAiCBT services, along with the MindBeacon digital therapy platform. The deal expands GreenShield Health’s mental health capabilities and grows its national footprint—particularly in Western Canada and Quebec—while integrating the acquired offerings into GreenShield+.
Corus Orthodontists Inc. announced a C$20 million institutional equity investment led by ATB Financial’s private equity arm, with co-investment from a prominent Canadian family office. The funding is intended to support further clinic expansion across the U.S. and Canada and to provide progressive equity liquidity to Corus’ existing shareholders.
WELL Health Technologies Corp. acquired a majority 61% ownership interest in E-Consult Canada LP for approximately CAD 33 million and completed the acquisition effective February 1, 2026. In addition, WELL acquired eight primary care clinics in Alberta (closing December 1, 2025), taking 100% ownership of the clinic business through its absorption model.
Elevate Farms Inc. acquired 100% of Fieldless Farms Inc., making Fieldless a wholly owned subsidiary of Elevate. The deal brings together Elevate’s controlled-environment agriculture (CEA) technology platform with Fieldless’s Cornwall, Ontario pesticide-free leafy greens operations, aiming to strengthen Canadian food sovereignty and enable global expansion.
Full Export
Get the full acquisitions list for this page as CSV + XLSX.
Find buyers actively acquiring healthcare services companies.
The page’s listed deals include diagnostic imaging clinics, pharmacy banner locations, healthcare service operators, and healthcare product companies (pharmaceutical and medical device businesses).
Recent listings reference deals across Canada, including Alberta, Ontario, Quebec, and British Columbia.
Both appear. The page includes acquisitions (for example, definitive share purchase agreements and business combination closings) and strategic minority investment announcements (for example, Walter Capital Partners investing in Altea Active Club).
Yes. One listed transaction describes a court-approved reverse-vesting process tied to Premier Health of America’s Québec restructuring, where operating affiliates exited creditor protection as going concerns.